Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Open accessThe DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
: 1. After 50 years of antipsychotic drug development focused on the dopamine D2 receptor, schizophrenia remains a chronic, disabling disorder for most affected individuals. 2. Studies over the last decade demonstrate that administration of low doses of NMDA receptor antagonists can cause in normal subjects the negative symptoms, cognitive impairments and physiologic disturbances observed in schizophrenia. 3. Furthermore, a number of recently identified risk genes for schizophrenia affect NMDA receptor function or glutamatergic neurotransmission. 4. Placebo-controlled trials with agents that directly or indirectly activate the glycine modulatory site on the NMDA receptor have shown reduction in negative symptoms, improvement in cognition and in some cases reduction in positive symptoms in schizophrenic patients receiving concurrent antipsychotic medications. 5. Thus, hypofunction of the NMDA receptor, possibly on critical GABAergic inter-neurons, may contribute to the pathophysiology of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overactivity of NMDA receptors causing excitotoxicity is a proposed underlying mechanism for epilepsy, dementia, and stroke, whereas low activity produces symptoms of schizophrenia.2–4”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The prefrontal cortex (PFC) and hippocampus stand out as major regions affected in schizophrenia”
From Adolescent Onset of Cortical Disinhibition in Schizophrenia: Insights From Animal Models (2011) · cites this paper as [3]
In the citing paper
“A loss of scaffolding proteins in spines could alter glutamatergic receptor signaling, disruption of which is theorized to contribute to the etiology of schizophrenia60.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [60]
In the citing paper
“Overactivity of NMDA receptors causing excitotoxicity is a proposed underlying mechanism for epilepsy, dementia, and stroke, whereas low activity produces symptoms of schizophrenia.2–4”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · cited 1×
“Existing drugs are poorly tolerated and exhibit little differences in efficacy (Lieberman et al., 2005).”
BackgroundKrystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · cited 2×
“Newcomer et al. (1999) extended the findings of Krystal et al. (1994) by showing that declarative memory, the form impaired in schizophrenia, was quite sensitive to low dose ketamine infusion.”
BackgroundRecent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · cited 1×
“Based upon the emerging pharmacology of the NMDAR, Javitt and Zukin (1991) proposed that the psychotomimetic effects of PCP were due to blockade of the NMDA receptors.”
BackgroundTripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529 · cited 1×
“The glutamatergic synapse consists of a tight functional relationship among the presynaptic terminal, the postsynaptic spine and the ensheathing astrocyte end-foot (Araque et al., 1999; Coyle et al., 2002).”
BackgroundSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
The hippocampal-VTA loop: controlling the entry of information into long-term memory
Lisman, J. E., & Grace, A. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.002 · Cited by 1,983
Braff, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,705
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393 · cited 2×
“In addition, clozapine treatment has been associated with reduction in the rate of suicide, reduction in smoking and reduction in abuse of other substances in schizophrenic patients (Drake et al., 2000; Meltzer et al., 2003; Zimmet et al., 2000).”
BackgroundLesion of striatal neurons with kainic acid provides a model for Huntington's chorea
COYLE, J. T., & SCHWARCZ, R. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,248 · cited 1×
“We focused on glutamatergic signal transduction before there was any evidence that it could be relevant to neuropsychiatric disorders (Coyle and Schwarcz, 1976).”
BackgroundSelf-citation
Research works printed but not linked: 1
- Wang, X., He, G., Gu, N., Yang, J., Tang, J., Chen, Q., et al. (2004). Association of G72/G30 with schizophrenia in the Chinese population. Biochem. Biophys. Res. Commun. 319:1281–1286. · DOI
Cited by
Items 801–900 of 954
Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., & Henderson, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3471-8.00045-7 · Cited by 4
McCullumsmith, R. E., & Rowland, L. M. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.07.020 · Cited by 1
Brown, N. K., Roche, J. K., Farmer, C. B., & Roberts, R. C. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02593-x · Cited by 1
“Glutamatergic dysregulation is a consistent finding in schizophrenia and is present in several brain regions (Coyle 2006; O’Donovan et al.”
BackgroundShahpesandy, H. (2023) · World Journal of Neuroscience · doi:10.4236/wjns.2023.131004 · Cited by 1
Analyzing the Dynamics Between Theory of Mind, Speech Disorders, and Brain Rewiring in Aphasia
Lopez-Soto, T. (2023) · Logic, argumentation & reasoning · doi:10.1007/978-3-031-46742-4_9 · Cited by 1
Neurobiology of Mental Disorders
Horn, K., Barrera, A., Haseeb, A., & Machado‐Vieira, R. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009334730.007 · Cited by 1
Liu, Y.-A., Wang, T., Chen, W.-C., Chen, P., & Chen, Y.-C. (2025) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_10_25 · Cited by 1
Pathological Synaptic Plasticity in Neurological Disorders
Jin, C., & Karlstedt, K. (2025) · Synaptic Plasticity - Neurobiology, Neuroanatomy, and Clinical Neuroscience · doi:10.5772/intechopen.1007753 · Cited by 1
Lutgen, V. (2012) · e-Publications@Marquette (Marquette University) · Cited by 2
Bakker, P. R. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120523pb · Cited by 1
Novel schizophrenia risk genesand gene expression
Knight, D. A. (2012) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Common Gene Variants in Schizophrenia Susceptibility with Focus on Neurodevelopment
Kähler, A. K. (2009) · NORA - Norwegian Open Research Archives · Cited by 1
Balz, J. (2018) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-407 · Cited by 1
Bortolozzi, A. A., Díaz-Mataix, L., & Artigas, F. (2007) · Wiley eBooks · doi:10.1002/9783527619337.ch8 · Cited by 1
Brown, J. M., Li, J. J., & Sinz, M. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc103.pub2 · Cited by 1
Wiltschko, W., Kramer, B., Winklhofer, M., Lohmann, K. J., Lohmann, C. M. F., Fransson, P., Ioannides, A. A., Boeke, H., Salcedo, E., Restrepo, D., et al. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_13 · Cited by 1
NEUROPEPTIDE Y (NPY) AND GLUTAMATE TRANSPORTER (GLAST) IN BEHAVIORAL MODELS OF PSYCHIATRIC DISORDERS
Karlsson, R. (2008) · Figshare · Cited by 1
Wolf, J. A., Moyer, J. T., & Finkel, L. H. (2009) · Advances in behavioral biology · doi:10.1007/978-1-4419-0340-2_14
Endothelial and inflammation markers in schizophrenia and bipolar disorder
Dieset, I. (2013) · NORA - Norwegian Open Research Archives
Gallant, S. (2014) · Spectrum Research Repository (Concordia University)
Madularu, D. (2014) · Spectrum Research Repository (Concordia University)
Corriveau, J. A. (2015) · OpenCommons at University of Connecticut (University of Connecticut)
Biological mechanisms behind clozapine- induced agranulocytosis
Lahdelma, L. (2009) · Työväentutkimus Vuosikirja · Cited by 1
Percepção visual de contraste em portadores de esquizofrenia e parentes não acometidos
Nogueira, R. M. T. B. L. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.47.2010.tde-30072010-103810 · Cited by 1
Gil, J. L. (2009) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Schizophrenia: Biological Mechanisms
Perrone‐Bizzozero, N. I., & Bullock, W. M. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb669
Korostenskaja, M. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 1
The role of miR-137 in schizophrenia
Wright, C. L. (2014) · UNM’s Digital Repository (University of New Mexico)
Hiperactivacion cortical y deterioro cognitivo en esquizofrenia
Bonnelly, S., & Vanessa, J. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Characterization of the D-amino acid oxidase interactome
Popiolek, M. (2010) · UCL Discovery (University College London)
Adaptations neuronales dans les maladies psychiatriques associées à une hyperdopaminergie
Rawas, R. E. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Anti-N-methyl-D-aspartate receptor encephalitis in China
Li, L., Wang, C., & Zhao, G. (2014) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.135571
“[9] It has been proven that over-activation of NMDARs is a potential mechanism for the occurrence of seizures, dementia and stroke, while the under-activation of NMDARs is involved in schizophrenia-like symptoms.[10,11] In addition, NMDARs are known to mediate central sensitization in the pathogenesis of chronic pain…”
Joseph, J., Gara, M. A., & Silverstein, S. M. (2015) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2015.03.003
“GAD67 protein expression has been shown to be reduced in postmortem schizophrenia brains (Addington et al., 2005; Guidotti et al., 2000) especially in cortical areas (Coyle, 2006; Lewis et al., 1999).”
Reconstructing Models from Proteomics Data
Zografos, L., Pocklington, A. J., & Armstrong, J. D. (2012) · Springer eBooks · doi:10.1007/978-94-007-3858-4_2
Levels of Ionotropic Glutamate and Muscarinic Receptors in Three Animal Models of Schizophrenia
Dean, B. (2011) · The Open Neuropsychopharmacology Journal · doi:10.2174/1876523801104010025
“Importantly, it has been noted that both pre- or peri-natal insults are associated with an increased risk of schizophrenia [2].”
BackgroundFiliou, M. D. (2010) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.12539
The kynurenine pathway and development of schizophrenia : Immunological and genetic aspects
Holtze, M. (2011) · Figshare
Emergence of A New Entity: The Autoimmune Encephalitis
Ahmad, Q., Ali, M., Kabir, M. A., Alahi, M., Amin, M., & Kafiluddin, M. (2012) · Journal of Medicine · doi:10.3329/jom.v13i2.12755
Gedächtnisdefizite nach Läsionen des medialen Temporallappens
Finke, C. (2013) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8387
Kohl, M. M. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6779
Herpesvirus Infection and Immunity in Neurocognitive Disorders
Westman, G. (2015) · Uppsala University Publications (Uppsala University)
Social dysfunction and mental retardation
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.010 · Cited by 1
EFFECTS OF D-SERINE ON VISUAL WORKING MEMORY IN MACAQUE MONKEYS
Manjunath, J. (2013) · QSpace (Queen's University Library)
Bouwer, S. (2010) · UWA Profiles and Research Repository (University of Western Australia)
Mahdavi, A., Mirjalili, M., Bahrami, F., & Janahmadi, M. (2015) · National and International Iranian Conference on Biomedical Engineering (ICBME) · doi:10.1109/icbme.2015.7404134
“On the other hand, glutamate hypothesis expresses that there is a hypofunction in NMDA receptors [2].”
BackgroundRein, B. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5228
Studying chemical and electrical neuronal dynamics as a platform for understanding schizophrenia
Das, T. K., Rajakumar, N., & Jog, M. (2013) · Journal of Coupled Systems and Multiscale Dynamics · doi:10.1166/jcsmd.2013.1029
Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia
Mielnik, C. A., & Ramsey, A. J. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622499-00115
Domingues, D. S. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2015.tde-03102015-152159
Andrade, G. N. (2015) · CUNY Academic Works (City University of New York)
Assessment of genetic and environmental factors in animal models of schizophrenia
Bitanihirwe, B. K. Y. (2011) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-006688010
Mutant and Transgenic Tools in Modeling Schizophrenia
Desbonnet, L., Tomiyama, K., Koshikawa, N., O'Tuathaigh, C., & Waddington, J. (2010) · Neuromethods · doi:10.1007/978-1-60761-474-6_12
Effects of aripiprazole vs. haloperidol on brain activity in healthy volunteers
Bolstad, I. (2016) · NORA - Norwegian Open Research Archives
Singer, P. (2008) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005774898
Sachdeva, P., Rohit, R., Sharan, P., & Prakash, K. (2016) · Journal of Neurological Disorders · doi:10.4172/2329-6895.1000297
“Over activity of NMDA receptors causing excitotoxicity is a proposed underlying mechanism for epilepsy, dementia, and stroke, whereas low activity produces symptoms of schizophrenia [3-5].”
BackgroundThe Effects of Atypical Antipsychotics on Implicit Reward Learning in Schizophrenia
Bradford, L. (2015) · QSpace (Queen's University Library) · Cited by 2
Nerhus, M. (2017) · NORA - Norwegian Open Research Archives · Cited by 1
Probing brain function with pharmacological MRI
Gozzi, A. (2011)
Loureiro, C. M. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-10012017-094940
Are There Schizophrenia Genetic Markers and Mutations? A Systematic Review and Meta-Analyses
Cardoso, M. A. B. S., do Nascimento, T. J., Bernardo, G. P., Bernardo, L. P., Barbosa, M. M. F. L., Neto, P. J. N., de Sousa, D. F., Júnior, A. G. T., de Lima, M. A. P., Moreira, M. M., et al. (2017) · Health · doi:10.4236/health.2017.95058
“There is considerable evidence suggesting the involvement of ionotrophic glutamate receptors in SCZ [95] [96].”
BackgroundInfluentialDoucet, J.-S. (2012) · TSpace (University of Toronto)
Moutoussis, M., Prabhu, G., & Dolan, R. J. (2015) · Cited by 1
Modeling Schizophrenia in Animals: Old Challenges and New Opportunities
Ayhan, Y., Terrillion, C. E., & Pletnikov, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00028-8
A Case of Catatonia Later Diagnosed with NMDA Receptor Encephalitis
Lee, S., Chon, M., Lee, J. S., & Kim, C.-Y. (2017) · Korean Journal of Schizophrenia Research · doi:10.16946/kjsr.2017.20.1.23
Understanding the risk and functional importance of schizophrenia genetic factors
Cheah, S.-Y. (2016) · Queensland University of Technology · doi:10.5204/thesis.eprints.101340
Ross, J. B. D. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-12012017-145100
Sex hormones and schizophrenia: from animal behavioural models to gene targets
Sun, J. (2018) · Minerva Access (University of Melbourne)
A 1H-MRS and Neurocognitive Analysis of Psychotic Symptoms in Stimulant Dependence
Lakusta, B. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3q04w
Aborowa, R. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6789
Nunes, E. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-17102018-104056
Wright, A. C. (2019) · Sussex Research Online (University of Sussex)
Effect of MK-801 Treatment and Endurance Training on Angiogenic Response in Cardiac Muscle
Hong, Y.-P., & Yeo, H. (2019) · Exercise Science · doi:10.15857/ksep.2019.28.2.150
Theta-Burst-induzierte Plastizität bei Schizophrenie
Brinkmann, C. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7354
Andersen, E. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ejcr-pd93
Misewitsch, K. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7584
NEGATIVE ALLOSTERIC MODULATION OF NMDA RECEPTORS WITH GLUN2A GAIN-OF-FUNCTION MUTATIONS
Farnsworth, J. C. (2019) · ScholarWorks at University of Montana
Farmacogenética da esquizofrenia
de Souza, R. P. (2009) · Americanae (AECID Library)
Nunes, E. A. (2019) · Archives of Pharmacy & Pharmacology Research · doi:10.33552/appr.2019.02.000533
Miranda, L. F. C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2020.tde-03102019-105248
Regulation mechanisms of human D-amino acidoxidase
Murtas, G. (2019) · IrInSubria (University of Insubria)
Cognitive Neurophysiology and in vivo Neurochemistry of Bipolar Disorder
Ilhan, A. M. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200527ma
The Role Of D-Serine In Normal Retinal Function And Implications For Psychiatry
Jimenez, N. T. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
Leppik, L. (2021) · DSpace repository (University of Tartu) · Cited by 7
Prenatal inflammation and neurodevelopmental disorders: The role of cytokines
Aguilar‐Valles, A. (2011)
Determining the Role of Psychiatric Nurse for Client Receiving Anti-Psychotic Drugs in India
Wanjari, M. B., Mendhe, D. M., & Wankhede, P. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i57a33985
“In response to the severe side effects of many typical antipsychotics, drug manufacturers developed another category referred to as atypical antipsychotics [3].”
BackgroundWarken, M., Hambsch, N., Tews, B., dos Santos, M. M., Niggemann, P., & Wolf, J. (2022) · DGNeurologie · doi:10.1007/s42451-022-00412-3
Kano, M., & Watanabe, T. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733168960.793562671
McArthur, R. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.05001-0
Yamada, K., & Nabeshima, T. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_3421
Nerhus, M., Melle, I. S., Hanssen‐Bauer, K., Bjella, T. D., Andreassen, O. A., Steen, N. E., & Lagerberg, T. V. (2022) · doi:10.2196/preprints.40442
Alkali, I. Y., Garba, M. M., Ya’u, J., Fakurazi, S., & Pender, G. C. (2023) · African Journal of Pharmaceutical Sciences · doi:10.51483/afjps.3.2.2023.29-44
Delirium due to Trousseau syndrome treated with memantine and perospirone: A case report
Yamaguchi, J., Hirayama, T., Sadahiro, R., Nakahara, R., & Matsuoka, H. (2023) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.159
“Besides, as for the rapid improvement, memantine is reported to have effects on brain infarction within 5 days by lowering matrix metalloproteinases ‐ 9, which is associated with the development of delirium.”
BackgroundZidovudine reduces ketamine-induced psychotic symptoms in mice
Ahmadu, P. U., Ejiofor, J. I., Chindo, B. A., Husseini, I. M. E., & Ameh, S. F. (2023) · Journal of Phytomedicine and Therapeutics · doi:10.4314/jopat.v22i2.3
Synthesis of classical and light activated ligands for the glutamatergic transmission
Cristiano, N. (2020) · theses.fr (ABES) · doi:10.70675/53bb11abz79ecz4d08zbda5zcf3e28a3fc12
Leclercq, S. (2023) · theses.fr (ABES) · doi:10.70675/cd59d3c2za8e5z4e97z9b95z8d6f0b38f79f
Multilevel-Untersuchung des nitrinergen Systems bei affektiven Störungen und schizophrenen Psychosen
Kehrwald, C. (2024) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.85806
Synaptic Plasticity - Neurobiology, Neuroanatomy, and Clinical Neuroscience
Mavroudis, I. A. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1003581 · Cited by 1
Metadata
- Authors
- Coyle, J. T.
- Affiliations
- Harvard University (US)
- Corresponding author
- Coyle, Joseph T.
- ORCID
- Coyle, Joseph T.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2006-06-14
- Volume
- 26
- Issue
- 4-6
- Pages
- 363-382
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- PMC
- PMC11881825
- OpenAlex
- W2008639041
- Cited by
- 917
- References
- 159
- Citations by year
- 2026: 13 · 2025: 27 · 2024: 16 · 2023: 29 · 2022: 29 · 2021: 28 · 2020: 35 · 2019: 47 · 2018: 43 · 2017: 44 · 2016: 45 · 2015: 56 · 2014: 47 · 2013: 74 · 2012: 62
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Cellular and Molecular Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (P50MH060450, MH P50-60450, MH R01-572901)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, glutamate, NMDA receptor, dopamine hypothesis, negative symptoms, cognitive impairment, NMDA receptor antagonists, schizophrenia risk genes, GABAergic interneurons, antipsychotic drugs, glutamatergic neurotransmission
- MeSH terms
- Animals, Dopamine, Glutamates, Humans, Models, Biological, Synaptic Transmission, Schizophrenia, Antipsychotic Agents, Receptors, N-Methyl-D-Aspartate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.